Population pharmacokinetic model of PI-88, a heparanase inhibitor
- 作者Susan F. Hudachek; S. Gail Eckhardt; Barbara Hicks; Daniel L. Gustafson
- 卷第65卷
- 期第4期
- 印刷ISSN0344-5704
- 电子ISSN1432-0843
- 文件大小406.22KB
- 发表时间2010-03
- DOI10.1007/s00280-009-1080-z
- 页码743-753
The Potential Beneficial Effects of Drugs on the Immune Response to VaccinationWai M. Liu; Angus G. Dalgleish · 2012
The antimalarial agent artesunate possesses anticancer properties that can be enhanced by combination strategiesWai M. Liu; Andrew M. Gravett; Angus G. Dalgleish · 2011
Gemcitabine and lenalidomide combination in a patient with metastatic pancreatic cancer: a case studyWai M. Liu; Shiyam Nizar; Angus G. Dalgleish · 2010
Cannabis-Derived Substances in Cancer Therapy – An Emerging Anti-Inflammatory Role for the CannabinoidsM. Liu, Wai; W. Fowler, Daniel; G. Dalgleish, Angus · Current Clinical Pharmacology · 2010
The gene expression profile of unstimulated dendritic cells can be used as a predictor of functionWai M. Liu; Jayne L. Dennis; Daniel W. Fowler; Angus G. Dalgleish · 2012
In vitro study of the anti-cancer effects of artemisone alone or in combination with other chemotherapeutic agentsAndrew M. Gravett; Wai M. Liu; Sanjeev Krishna; Wing-Chi Chan; Richard K. Haynes; Natalie L. Wilson; Angus G. Dalgleish · 2011
A microarray study of altered gene expression in colorectal cancer cells after treatment with immunomodulatory drugs: differences in action in vivo and in vitroWai M. Liu; Holger Laux; Jake Y. Henry; Thomas B. Bolton; Angus G. Dalgleish; Christine Galustian · 2010